Skip to main content

Table 2 Mismatch repair IHC testing results

From: Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations

GENE Antibody Result
MLH1 G168-15 Normal expression
PMS2 A16-4 Normal expression.
MSH6 BC/44 Loss of expression.
MSH2 FE11 Loss of expression.